Cargando…
A Drosophila Mitochondrial Complex I Deficiency Phenotype Array
Mitochondrial diseases are a group of rare life-threatening diseases often caused by defects in the oxidative phosphorylation system. No effective treatment is available for these disorders. Therapeutic development is hampered by the high heterogeneity in genetic, biochemical, and clinical spectra o...
Autores principales: | Foriel, Sarah, Renkema, G. Herma, Lasarzewski, Yvonne, Berkhout, Job, Rodenburg, Richard J., Smeitink, Jan A. M., Beyrath, Julien, Schenck, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445954/ https://www.ncbi.nlm.nih.gov/pubmed/30972103 http://dx.doi.org/10.3389/fgene.2019.00245 |
Ejemplares similares
-
Feeding difficulties, a key feature of the Drosophila NDUFS4 mitochondrial disease model
por: Foriel, Sarah, et al.
Publicado: (2018) -
Live-Imaging Readouts and Cell Models for Phenotypic Profiling of Mitochondrial Function
por: Iannetti, Eligio F., et al.
Publicado: (2019) -
Sonlicromanol’s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth
por: Jiang, Xiaolan, et al.
Publicado: (2021) -
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery
por: Beyrath, Julien, et al.
Publicado: (2018) -
A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms (“KHENERGYC”)
por: Smeitink, Jan, et al.
Publicado: (2022)